Friends! In this video, I'm going to discuss 2 cheap quality stocks to consider in this heated market.
2 extracted signals · 2 resolved · 0 still active
The Patient InvestorIndependent analyst profile- Source published
- 11 Oct 2025, 19:05 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The analysis identifies META and AMZN as potential outperformers over the next 20 days. META, currently at $705.30, is noted for its 3.5 billion daily active users and disciplined expense management. A target price is near 1283.29. The analysis emphasizes META's potential for monetization and innovation with a 15% EPS growth over 5 years. AMZN, now down 1% year to date, is recognized for its logistics mode and potential catalyst with the Anthropic partnership in AI. AMZN has the potential target price of 300. Both stocks benefit from poor current sentiment and are growth stories.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
The Patient Investor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

